January 14, 2025
Paris, Riom, Delray Beach, Florida – VERDOT, supported by its majority shareholders, Qualium Investissement and Lauxera Capital Partners, is pleased to announce a €10 million investment from BioProcess360, a specialized, US-based investment fund focused on the bioprocessing and life sciences sectors. With this strategic investment, BioProcess360 becomes an active shareholder in VERDOT alongside Qualium Investissement, [...]
SepSolve Analytical unveils enhancements to BenchTOF2 for superior performance
January 13, 2025
SepSolve Analytical (Peterborough, UK) has unveiled significant upgrades to its highly regarded BenchTOF2 time-of-flight mass spectrometer. Renowned for its high mass accuracy, exceptional spectral quality, and trace-level sensitivity, the BenchTOF2 now delivers even greater performance, solidifying its position as the ideal solution for non-target screening and demanding analytical applications. The updated BenchTOF2 features a redesigned ion source that enhances robustness [...]
January 13, 2025
Study will generate a key reference data set with Illumina Protein Prep solution SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis. The [...]
January 13, 2025
Experienced healthcare leader with more than 20 years of demonstrated success driving industry growth and transformation takes helm at global genomics company CORALVILLE, Iowa and REDWOOD CITY, Calif. — Global genomics solutions leader Integrated DNA Technologies (IDT) has appointed Ajay Gannerkote as president, effective immediately. With a track record of driving growth and transformation across myriad [...]
Illumina and NVIDIA collaborate to decode biology and propel precision health
January 13, 2025
Collaboration combines Illumina's sequencing technologies and Illumina Connected Software with NVIDIA tools to develop biological foundation models SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data, accelerating progress in clinical research, [...]
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
January 13, 2025
BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the launch of Platinum® Pro, its latest benchtop sequencer that sets a new standard in protein analysis. Designed to redefine efficiency and versatility in proteomics research, Platinum Pro is now available for ordering. Platinum Pro delivers a comprehensive solution for [...]
January 13, 2025
Professors Anders Bentien, Walter Gössler, and Gregory Offer are recognized for their work in battery research SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of Aarhus University, Professor Walter Gössler of University of Graz, and Professor Gregory Offer of Imperial College London. These separate [...]
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
January 13, 2025
WALTHAM, Mass. & SAN DIEGO -- Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow [...]
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
January 13, 2025
WALTHAM, Mass. & SAN DIEGO -- Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life science company democratizing access to advanced DNA and multi-omic sequencing solutions. This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow [...]
January 13, 2025
DALLAS -- Almaden Genomics has announced g.nome® 2.0, a significant upgrade to its flagship platform to empower researchers and biologists with enhanced data analysis capabilities and streamlined workflows. These enhancements further the company’s mission to make bioinformatics tools more accessible, efficient, and powerful for the life sciences industry. Key among the new features is the introduction [...]

